ATHN Stock UPDATES Athenahealth (ATHN) 113.76 10/22/2014 05:

New Post Public Reply Private Reply Replies (0) Message Board

Oct 22, 2014 at 6:36 AM

Athenahealth (ATHN) 113.76 $ATHN

Einhorn: Selloff Created Buying Opportunities, Embrace Higher Interest
at The Street - Tue Oct 21, 2:09PM CDT
The trading panels hosts hedge fund manager David Einhorn and looks at what to make of earnings from Coca-Cola, McDonald's and Chipotle.
KO: 40.68 (-2.61), CCI: 84.52 (+2.06), MU: 31.19 (+1.50), VRX: 130.38 (+5.60), WWE: 13.82 (-0.63), SPWR: 31.76 (+1.41), INTC: 32.61 (+1.03), ATHN: 113.76 (+0.64), AGN: 186.16 (+6.91), NFLX: 365.99 (+6.77), FIG: 6.77 (+0.40), SUNE: 19.05 (+1.15), TXN: 46.77 (+2.36), CMG: 607.55 (-45.48), AAL: 37.85 (+2.63), MCD: 91.01 (-0.58), AAPL: 102.47 (+2.71)

athenahealth Q3 Earnings Fall but Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 9:30AM CDT
For the full year 2014, athenahealth (ATHN) reiterated its revenues guidance of $725 to $755 million
ZLTQ: 22.98 (+0.48), GWPH: 73.04 (+5.05), OMCL: 27.75 (+0.38), ATHN: 113.76 (+0.64)

athenahealth Has Returned 14.2% Since SmarTrend Recommendation (ATHN)
Comtex SmarTrend(R) - Mon Oct 20, 9:26AM CDT
SmarTrend identified a Downtrend for athenahealth (NASDAQ:ATHN) on September 15th, 2014 at $132.36. In approximately 1 month, athenahealth has returned 14.25% as of today's recent price of $113.50.
ATHN: 113.76 (+0.64)

athenahealth Set to Possibly Rebound After Yesterday's Selloff of 7.25%
Comtex SmarTrend(R) - Fri Oct 17, 4:32PM CDT
athenahealth (NASDAQ:ATHN) traded in a range yesterday that spanned from a low of $107.88 to a high of $117.56. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $117.75 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATHN: 113.76 (+0.64)

GE and Urban Outfitters are big market movers
AP - Fri Oct 17, 3:31PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
URBN: 30.24 (+0.05), GE: 25.45 (+0.42), CLV: 8.44 (-0.50), RPRX: 6.02 (-0.21), CLF: 8.54 (-0.40), ATHN: 113.76 (+0.64), MS: 34.06 (+0.74)

Stocks Up Big Friday, Recover Early Week Losses
at Investor's Business Daily - Fri Oct 17, 3:24PM CDT
Stocks finished with big gains Friday, posting their best day in six sessions. Blue chips led, with the Dow Jones industrial average rising 1.6%, while the S&P 500 climbed 1.3% and the Nasdaq finished 1.0% higher. Preliminary data show volume coming...
VRX: 130.38 (+5.60), GILD: 106.67 (+4.46), AKRX: 41.29 (+2.28), CMG: 607.55 (-45.48), ILMN: 179.55 (+15.08), DIS: 87.54 (+2.02), AAPL: 102.47 (+2.71), ATHN: 113.76 (+0.64)

What's Behind Athenahealth's So-So Earnings
Keith Speights, The Motley Fool - Motley Fool - Fri Oct 17, 1:14PM CDT
Investors looking for a return of high-flying momementum of the past from athenahealth might still be looking. The cloud-based health services company announced third quarter results Thursday that didn't cause much jubilation but weren't too...
ATHN: 113.76 (+0.64)

ATHENAHEALTH
at Investor's Business Daily - Thu Oct 16, 5:49PM CDT
ATHENAHEALTH (ATHN) said Q3 EPS fell 6.9% to 27 cents, in line with views. Revenue rose 25.7% to $190.43 bil vs. views for $190.4 bil. Shares fell 2% to 118.05.
ATHN: 113.76 (+0.64)

athenahealth, Inc. Reports Third Quarter Fiscal Year 2014 Results
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Company Announces Record Physician Additions
ATHN: 113.76 (+0.64)

Athenahealth reports 3Q loss
Automated Insights - Thu Oct 16, 3:31PM CDT
WATERTOWN, Mass. (AP) _ Athenahealth Inc. (ATHN) on Thursday reported a loss of $1.6 million in its third quarter.
ATHN: 113.76 (+0.64)

Will athenahealth, Inc. (ATHN) Beat Earnings this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:40AM CDT
Our proven model does not conclusively show that athenahealth, Inc. (ATHN) is likely to beat earnings this quarter.
ABAX: 49.36 (+1.11), HTWR: 81.49 (+1.59), HOLX: 24.76 (+0.75), ATHN: 113.76 (+0.64)

5 Hated Earnings Stocks You Should Love
at The Street - Tue Oct 14, 11:53AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
CNS: 40.31 (+0.69), CPHD: 48.14 (+1.58), BGG: 18.83 (+0.51), LVS: 64.54 (+1.62), ATHN: 113.76 (+0.64)

3 Keys for athenahealth, Inc. to Regain Its Sizzle
Keith Speights, The Motley Fool - Motley Fool - Mon Oct 13, 9:31AM CDT
For investors accustomed to their stock's price tripling over a five-year period, athenahealth 's performance in 2014 has been quite disappointing. The online healthcare services company's shares are down for the year and have dropped 16% since the...
ATHN: 113.76 (+0.64)

The One Technology Which Could Help Stop the Spread of Ebola
Leo Sun, The Motley Fool - Motley Fool - Sun Oct 12, 10:45AM CDT
The Ebola epidemic, which has already caused over 3,800 deaths across West Africa, recently claimed its first victim within the U.S. -- Thomas Eric Duncan, a Liberian man who was visiting family in the Dallas area. Duncan was initially admitted to...
GOOGL: 538.03 (+5.65), GOOG: 526.54 (+5.70), AAPL: 102.47 (+2.71), CERN: 59.18 (+0.86), ATHN: 113.76 (+0.64)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
AUO: 4.00 (+0.14), BWS: 27.89 (+0.58), ABTL: 9.12 (+0.38), AFSI: 49.95 (+4.52), ATHN: 113.76 (+0.64)

athenahealth Recognized for Excellence in KLAS EMR Interoperability 2014 Report
GlobeNewswire - Tue Oct 07, 8:06AM CDT
athenahealth, Inc. (Nasdaq:ATHN), a leading provider of cloud-based services and mobile tools for medical groups and health systems, today announced its recognition as a leader in interoperability in the KLAS EMR Interoperability 2014 report. The report, which was released today, surveyed 220 participants across inpatient and ambulatory settings. Practices as small as 1 to 10 providers and hospitals with more than 1,000 beds were included in the survey.
ATHN: 113.76 (+0.64)

Critical Alerts For Zynga, Disney, ConocoPhillips, athenahealth and Ctrip.com Released By InvestorsObserver
PR Newswire - Mon Oct 06, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ZNGA, DIS, COP, ATHN and CTRP.
COP: 70.59 (+1.76), DIS: 87.54 (+2.02), CTRP: 57.34 (+2.07), ZNGA: 2.43 (+0.14), ATHN: 113.76 (+0.64)

Don't Miss Out on These 3 Top Healthcare Growth Stocks
Simon Erickson and Michael Douglass, The Motley Fool - Motley Fool - Wed Oct 01, 2:52PM CDT
Healthcare is a trillion-dollar industry in America alone, and the opportunities for investors to profit from it are absolutely incredible. However, the complexity of technical information (i.e., hard to pronounce drug names) and significant...
VEEV: 28.53 (+0.22), CTRX: 41.68 (+1.36), ATHN: 113.76 (+0.64)

athenahealth, Inc. Announces Third Quarter 2014 Earnings Conference Call
GlobeNewswire - Mon Sep 29, 8:00AM CDT
athenahealth, Inc. (Nasdaq:ATHN) (the "Company"

, a leading provider of cloud-based services and mobile tools for medical groups and health systems, today announced that it will hold a conference call for investors on Friday, October 17, 2014, at 8:00 a.m. ET. During the conference call, management will review highlights from the Company's third quarter 2014 results, which will be announced via press release after the close of market trading on Thursday, October 16, 2014.
ATHN: 113.76 (+0.64)

Immunomedics Inc. (IMMU) Jumps: Stock Up 6.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 8:39AM CDT
Immunomedics Inc. (IMMU) was a big mover last session, as the company saw its shares rise almost 7% on the day.
IMMU: 3.65 (unch), CBM: 17.88 (+0.14), GILD: 106.67 (+4.46), ATHN: 113.76 (+0.64)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...